Individual susceptibility has a major impact on strong association between oxidative stress, defence systems and Parkinson's disease
Open Access
- 28 September 2021
- journal article
- research article
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 130 (1) , 158-170
Abstract
Oxidative stress plays an important role in the degeneration of dopaminergic neurons, which causes Parkinson's disease (PD). Oxidative stress products, antioxidant and their balance have important roles in the development of oxidative stress‐based PD. The impact of reactive oxygen species (ROS) and defence systems can be altered by genetic polymorphisms, and thus the risk of PD may also be affected. We aimed to investigate the possible association of individual susceptibility with the development of oxidative stress‐based PD. For this purpose, we measured serum levels of folic acid, homocysteine, Vitamin B6 and B12 that play roles in folate‐dependent one‐carbon pathway, oxidant or antioxidant enzymes (NADPH oxidase, MnSOD, GPX), 8‐OHdG and repair enzymes (OGG1, XRCC1 and MTH1) by ELISA, and analysed related gene polymorphisms by PCR‐RFLP. XRCC1, ROS, NADPH and folic acid levels were found to be statistically higher in patients than controls. XRCC1, MnSOD and GPX activities were increased. We observed higher levels of 8‐OHdG in patients with MnSOD and XRCC1 mutant genotypes and higher XRCC1 levels in patients with NOX p22 fox mutant genotypes rather than controls. We suggest that routinely clinical validation of major oxidative stress‐related biomarkers will be a good approach to manage detrimental effects of PD.Keywords
Funding Information
- Gazi Üniversitesi (02/2015‐06)
This publication has 51 references indexed in Scilit:
- Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular SystemCirculation Research, 2012
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signalingCellular Signalling, 2012
- DNA Repair Genes in Parkinson's DiseaseGenetic Testing and Molecular Biomarkers, 2012
- Urinary 8-hydroxydeoxyguanosine correlate with hallucinations rather than motor symptoms in Parkinson’s diseaseParkinsonism & Related Disorders, 2011
- L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson’s diseaseJournal of Clinical Neuroscience, 2010
- Oxidative damage in Parkinson disease: Measurement using accurate biomarkersFree Radical Biology and Medicine, 2010
- 8-OHdG in Cerebrospinal Fluid as a Marker of Oxidative Stress in Various Neurodegenerative DiseasesNeurodegenerative Diseases, 2009
- Oxidative damage in nucleic acids and Parkinson's diseaseJournal of Neuroscience Research, 2007
- Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patientsMovement Disorders, 2004
- Systematic review of incidence studies of Parkinson's diseaseMovement Disorders, 2002